In a different study, high gene expression of a subset of MRPs including MRPL18 correlated with poor breast cancer survival (Huang et al., 2015), and predicted tumor recurrence and tamoxifen resistance (Sotgia et al., 2017). The gene discussed is MRPL18; the disease is breast carcinoma.